Health Readiness

Leptospirosis

Leptospirosis: The presence of leptospirosis in the Republic of Korea (ROK) poses a potential threat to more than 40,000 U.S. Armed Forces personnel and their family members who reside in the ROK. This is the first published study for risk assessment of leptospirosis among U.S. Army soldiers assigned to the ROK.

Staphylococcus

Staphylococcus: Staphylococcus aureus is a major cause of skin and soft tissue infection (SSTI). Military personnel in congregate settings (e.g., training, deployment) are at increased risk for S. aureus colonization and SSTI. For a 7-month period in 2016, an observational cohort study of S. aureus colonization and SSTI among U.S. Navy submariners was conducted.

Food Allergy

Individuals with a history of food-allergy anaphylaxis or a systemic reaction to food do not meet military accession or retention standards and require a waiver in order to serve in the military. First-line treatment for anaphylaxis includes rapid administration of epinephrine.

Acute Injuries

Service members in the U.S. Armed Forces frequently engage in high levels of physical activity to perform their duties, and such activity can potentially result in training- or duty-related injury. This report summarizes the incidence, trends, types, external causes, and dispositions of acute injuries among active component U.S. service members over a 10-year surveillance period.

Global Influenza Summary: July 8, 2018

Department of Defense Midseason Vaccine Effectiveness Estimates for the 2017-2018 Influenza Season

Diagnoses of Eating Disorders, Active Component Service Members, U.S. Armed Forces, 2013–2017 Eating Disorders

DHA PI 6025.07: Naloxone in the MTFs

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.

• Identification #: DHA PI 6025.07
• Date: 6/19/2018
• Type: DHA Procedural Instruction
• Topics: Health Readiness | TRICARE Pharmacy Program

Morbidity Burdens Attributable to Various Illnesses and Injuries

Morbidity Burdens Attributable to Various Illnesses and Injuries, Deployed Active and Reserve Component Service Member, U.S. Armed Forces, 2017

Ambulatory Visits, Active Component, U.S. Armed Forces, 2017

ACTIVE COMPONENT, U.S. ARMED FORCES, 2017 This report documents the frequencies, rates, trends, and characteristics of ambulatory healthcare visits of active component members of the U.S. Army, Navy, Air Force, and Marine Corps.

Morbidity Burdens Attributable to Various Illnesses and Injuries, Deployed Active and Reserve Component Service Member, U.S. Armed Forces, 2017

Absolute and Relative Morbidity Burdens, Attributable to Various Illnesses and Injuries, 2017

Hospitalizations, Active Component, U.S. Armed Forces, 2017

This report documents the frequencies, rates, trends, and distributions of hospitalizations of active component members of the U.S. Army, Navy, Air Force, and Marine Corps during calendar year 2017.

Global Influenza Summary: May 13, 2018

DHA PI 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the procedures for the FHPQA Program as defined in Reference (z). This DHA-PI applies to: a. OSD, the Military Departments (including the United States Coast Guard (USCG) at all times, including when it is a Service in the Department of Homeland Security by agreement with that Department), the Office of the Chairman of the Joint Chiefs of Staff (CJCS) and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the DoD, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD (referred to collectively in this DHA-PI as the “DoD Components”). b. Civilian personnel, as defined in Reference (e), and DoD contractor personnel authorized to accompany the force (CAAF), in accordance with References (j), (m), and (n), respectively.

• Identification #: DHA PI 6200.05
• Date: 5/2/2018
• Type: DHA Procedural Instruction
• Topics: Health Readiness